Vertex Pharmaceuticals (VRTX) EV to EBIT (2009 - 2026)

Vertex Pharmaceuticals (VRTX) EV to EBIT (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EV to EBIT
1	Genmab A	276,399.99 Bn	276,398.47 Bn	831.00 Mn	232,854.65
2	Akari Therapeutics	1,217.26 Bn	1,217.26 Bn	-	-41,251.84
3	BeOne Medicines	419.38 Bn	414.59 Bn	1.35 Bn	604.41
4	Vertex Pharmaceuticals	126.54 Bn	119.30 Bn	2.59 Bn	25.48
5	Pharming	110.17 Bn	110.12 Bn	65.80 Mn	10,112.54
6	Regeneron Pharmaceuticals	64.97 Bn	56.22 Bn	3.31 Bn	15.49
7	Argenx Se	56.44 Bn	56.44 Bn	1.18 Bn	43.12
8	Alnylam Pharmaceuticals	40.09 Bn	37.08 Bn	959.66 Mn	49.30
9	Revolution Medicines	37.15 Bn	37.15 Bn	-	-84.03
10	Moderna	28.64 Bn	23.43 Bn	-566.00 Mn	-6.87

Download Data